Get the Stockscreener App
14.11
0.97%
0.13
Grail Inc stock is traded at $14.11, with a volume of 135.96K.
It is up +0.97% in the last 24 hours and up +8.33% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
See More
Previous Close:
$13.98
Open:
$14.13
24h Volume:
135.96K
Relative Volume:
0.18
Market Cap:
$439.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+8.66%
1M Performance:
+8.33%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$13.75
$14.29
1-Week Range:
$12.78
$14.29
52-Week Range:
$12.33
$21.47
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
650-771-9796
Address
1525 O'BRIEN DRIVE, MENLO PARK
Grail Inc Stock (GRAL) Latest News
Grail (GRAL) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - WV News
GRAIL to Announce Third Quarter 2024 Financial Results - StockTitan
(GRAL) Trading Advice - Stock Traders Daily
Google: The Bullish Pivot Before The Earnings Grail (NASDAQ:GOOG) - Seeking Alpha
GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation - The Cancer Letter
Nike x Wu-Tang Clan Reunite to Release Legendary Sneaker Grail — NIKE, Inc. - Nike
Illumina Wins Court Fight With EU Over $7 Billion Grail Deal - MSN
Real-world study of Grail’s Galleri consistent with trial data - BioWorld Online
The Jeff Bezos-backed cancer treatment company is being sold for eight billion dollars - Telegrafi
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference - PR Newswire
Health Beat: The 'holy grail' of cancer screening - 69News WFMZ-TV
CEO & Director Of GRAIL Sold 51% Of Their Shares - Simply Wall St
Company commits not to try to crack ‘holy grail’ cement-free formula - Irish Independent
Grail appoints healthcare veteran Sarah Krevans to board By Investing.com - Investing.com Australia
Grail appoints healthcare veteran Sarah Krevans to board - Investing.com
GRAIL Appoints Sarah Krevans to Board of Directors - Quantisnow
Layoff Tracker: Takeda Cuts More Employees, Total Exceeds 1,300 in 2024 - BioSpace
Grail CEO Robert Ragusa sells $1.73 million in stock - Investing.com
How the (GRAL) price action is used to our Advantage - Stock Traders Daily
Health Headlines: Holy Grail of cancer screening - KPLC
GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now - Insider Monkey
Grail Inc. executive acquires over $1 million in company stock By Investing.com - Investing.com South Africa
Grail Inc. executive acquires over $1 million in company stock - Investing.com India
Best Life: The ‘Holy Grail’ for cancer screening - Action News 5
Illumina Grail: European Court Limits Commission Jurisdictional Reach in Merger Cases - JD Supra
Illumina falls amid reports of an EU order to sell Grail - MSN
The Taxpayer-Funded GRAIL Galleri-Medicare Study: A Flawed Design - healthaffairs.org
CRCM LP's Strategic Acquisition of GRAIL Inc Shares - GuruFocus.com
Biotech company Grail to lay off 350, more than half in Bay Area - MSN
GRAIL: Post-Spinoff, Illumina Maintains Control And Incentive To Support Success - Seeking Alpha
Closing Strong: GRAIL Inc. (GRAL) Ends at 13.04, Down -6.52 from Last Close - The Dwinnex
Gleeds to relocate to new Fitzrovia HQ - FMJ
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture - ANTARA English
Gleeds to move into new London HQ next January - Building
Ex-Linchpin director loses appeal of $150,000 penalty - Lawyerly
486 Shares in Graham Holdings (NYSE:GHC) Purchased by King Luther Capital Management Corp - Defense World
BreakingviewsLarry Fink’s private index dream may be holy grail - Reuters
John P. Mullen Sells 6,718 Shares of Guidewire Software, Inc. (NYSE:GWRE) Stock - Defense World
(09/18/24) GRAL: An Intriguing Biotech Name Active in Cancer Detection Test - Moneyshow.com
Illumina/Grail: EU Court overturns approach to “killer acquisitions” - JD Supra
With 59% ownership of the shares, GRAIL, Inc. (NASDAQ:GRAL) is heavily dominated by institutional owners - Simply Wall St
We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate - Yahoo Finance
Commission withdraws several decisions in the Illumina/GRAIL case - EU Reporter
Illumina/Grail case: CJEU annuls Commission’s referral decision - Cuatrecasas
Cœuré: Illumina/Grail decision will cause “more fragmented system” - Global Competition Review
Grail’s Potential Turnaround: Seeking FDA Approval For Galleri (NASDAQ:GRAL) - Seeking Alpha
GRAIL to focus on multi-cancer early detection; cuts workforce by 30% - MSN
Battery company says it's achieved breakthrough charging time with 'holy grail' of EV tech: 'This car [ticks] all the boxes' - The Cool Down
EU’s ability to challenge ‘killer acquisitions’ dealt a blow by Europe’s highest court - EURACTIV
Grail Inc Stock (GRAL) Financials Data
There is no financial data for Grail Inc (GRAL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.65%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):